Discover
RAPP
Rapport Therapeutics, Inc.
40.45
2 x 30.56
2 x 52.54
bid
ask
-
1.50
3.58%
2 @ 04:00 PM
40.45 +0.00 (0.00%)
| Ytd | 33.32% | |
| 1y | 47.90% |
40.28
day range
43.00
23.75
52 week range
52.93
| Open | 41.89 | Prev Close | 41.95 | Low | 40.28 | High | 43.00 | Mkt Cap | 1.94B |
| Vol | 998.06K | Avg Vol | 363.34K | EPS | -3.03 | P/E | N/A | Forward P/E | -7.74 |
| Beta | 1.03 | Short Ratio | 7.87 | Inst. Own | 108.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 44.78 | 200-d Avg | 35.49 | 1yr Est | 62.88 |
| Income Statement | |||
| Operating Expenses | 60.81M | ||
| Research and Development Expense | 51.41M | ||
| Selling, General and Administrative Expense | 9.39M | ||
| Operating Income | -60.81M | ||
| Net Income | -56.61M | ||
| Net Income Common Stock | -56.61M | ||
| Net Income Common Stock (USD) | -56.61M | ||
| Consolidated Income | -56.61M | ||
| Earnings per Basic Share | -1.19 | ||
| Earnings per Basic Share (USD) | -1.19 | ||
| Earnings per Diluted Share | -1.19 | ||
| Earning Before Interest & Taxes (EBIT) | -56.61M | ||
| Earning Before Interest & Taxes (USD) | -56.61M | ||
| Weighted Average Shares | 47.47M | ||
| Weighted Average Shares Diluted | 47.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 63.72M | ||
| Cash and Equivalents (USD) | 63.72M | ||
| Investments | 372.47M | ||
| Investments Current | 372.47M | ||
| Trade and Non-Trade Receivables | 293.00K | ||
| Current Assets | 446.86M | ||
| Property, Plant & Equipment Net | 11.07M | ||
| Total Assets | 458.98M | ||
| Debt Current | 2.47M | ||
| Total Debt | 10.11M | ||
| Current Liabilities | 28.42M | ||
| Debt Non-Current | 7.63M | ||
| Total Liabilities | 36.06M | ||
| Accumulated Retained Earnings (Deficit) | -311.70M | ||
| Accumulated Other Comprehensive Income | -1.27M | ||
| Shareholders Equity | 422.93M | ||
| Shareholders Equity (USD) | 422.93M | ||
| Assets Non-Current | 12.13M | ||
| Total Debt (USD) | 10.11M | ||
| Liabilities Non-Current | 7.63M | ||
| Trade and Non-Trade Payables | 2.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 807.00K | ||
| Net Cash Flow from Financing | 1.41M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.44M | ||
| Capital Expenditure | 115.00K | ||
| Issuance (Purchase) of Equity Shares | 1.59M | ||
| Net Cash Flow from Investing | 25.60M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 25.49M | ||
| Net Cash Flow from Operations | -41.45M | ||
| Share Based Compensation | 7.20M | ||